Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares OutstandingShares Outstanding
Ratios

Pliant Therapeutics (PLRX) Receivables - Other (2019 - 2026)

Pliant Therapeutics has reported Receivables - Other over the past 8 years, most recently at $914000.0 for Q1 2026.

  • Quarterly Receivables - Other fell 45.69% to $914000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $914000.0 through Mar 2026, down 45.69% year-over-year, with the annual reading at $823000.0 for FY2025, 64.25% down from the prior year.
  • Receivables - Other was $914000.0 for Q1 2026 at Pliant Therapeutics, up from $823000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $4.0 million in Q3 2022 and troughed at $320000.0 in Q2 2022.
  • The 5-year median for Receivables - Other is $1.7 million (2025), against an average of $1.8 million.
  • Year-over-year, Receivables - Other surged 639.06% in 2023 and then plummeted 64.25% in 2025.
  • A 5-year view of Receivables - Other shows it stood at $1.1 million in 2022, then soared by 178.01% to $3.0 million in 2023, then decreased by 23.19% to $2.3 million in 2024, then plummeted by 64.25% to $823000.0 in 2025, then rose by 11.06% to $914000.0 in 2026.
  • Per Business Quant, the three most recent readings for PLRX's Receivables - Other are $914000.0 (Q1 2026), $823000.0 (Q4 2025), and $908000.0 (Q3 2025).